Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HLCS antisense RNA 1 (HLCS-AS1) is a long non-coding RNA (lncRNA) gene found in humans, transcribed in the antisense orientation relative to the HLCS (Holocarboxylase synthetase) gene. As of current knowledge, its specific function, molecular mechanisms, and disease associations remain largely uncharacterized, with no established role as a drug target or biomarker. HLCS-AS1 is catalogued as a non-coding RNA gene by major bioinformatic resources but with no experimentally supported protein product or direct therapeutic relevance[3][5][7][9]. No evidence from curated databases or recent literature supports HLCS-AS1 as a receptor, enzyme, transporter, or other canonical drug target. Most available resources confirm its identity as a lncRNA gene, with no synonyms, validated gene function, or established role in disease[3][5][7][9]. There are no recognized interacting drugs, mechanisms of action, or usage as a biomarker or in patient selection, and there are no safety or therapeutic concerns described. If you are seeking a different antisense RNA (such as HNF1A-AS1 or NNT-AS1), please clarify since those have more established biological and disease roles[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HLCS antisense RNA 1 (HLCS-AS1).